SpringWorks Therapeutics
Stock Forecast, Prediction & Price Target
SpringWorks Therapeutics Financial Estimates
SpringWorks Therapeutics Revenue Estimates
SpringWorks Therapeutics EBITDA Estimates
SpringWorks Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $6.14M 0% | $5.44M -11.38% | Avg: $317.97M Low: $273.80M High: $351.90M avg. 5737.58% | Avg: $638.99M Low: $494.52M High: $745.52M avg. 100.95% | Avg: $1.17B Low: $909.34M High: $1.37B avg. 83.88% | Avg: $584.2M Low: $452.11M High: $681.59M avg. -50.28% |
Net Income
% change YoY
| $-173.21M N/A | $-274.16M -58.28% | $-325.10M -18.58% | Avg: $-241.40M Low: $-311.20M High: $-118.67M avg. 25.74% | Avg: $-70.18M Low: $-71.42M High: $-41.45M avg. 70.92% | Avg: $70.38M Low: $49.69M High: $85.63M avg. 200.27% | Avg: $-59.33M Low: $-72.19M High: $-41.89M avg. -184.30% |
EBITDA
% change YoY
| $-172.97M N/A | $-280.67M -62.25% | $-341.34M -21.61% | Avg: $-63.59M Low: $-70.38M High: $-54.76M avg. 81.36% | Avg: $-127.79M Low: $-149.10M High: $-98.90M avg. -100.95% | Avg: $-235.00M Low: $-274.17M High: $-181.86M avg. -83.88% | Avg: $-116.83M Low: $-136.31M High: $-90.42M avg. 50.28% |
EPS
% change YoY
| -$3.57 N/A | -$5.14 -43.97% | -$5.15 -0.19% | Avg: -$3.49 Low: -$4.93 High: -$1.88 avg. 32.16% | Avg: -$0.93 Low: -$1.13 High: -$0.66 avg. 73.37% | Avg: $1.12 Low: $0.79 High: $1.36 avg. 219.89% | Avg: -$0.94 Low: -$1.14 High: -$0.66 avg. -184.30% |
Operating Expenses
% change YoY
| $173.46M N/A | $280.67M 61.80% | $348.03M 24.00% | Avg: $3.87B Low: $3.34B High: $4.29B avg. 1014.58% | Avg: $7.79B Low: $6.03B High: $9.09B avg. 100.95% | Avg: $14.33B Low: $11.09B High: $16.72B avg. 83.88% | Avg: $7.12B Low: $5.51B High: $8.31B avg. -50.28% |
FAQ
What is SpringWorks Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 28.16% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -311.20M, average is -241.40M and high is -118.67M.
What is SpringWorks Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1468.03% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $273.80M, average is $317.97M and high is $351.90M.
What is SpringWorks Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 35.28% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$4.93, average is -$3.49 and high is $-1.88.
What is the best performing analyst?
In the last twelve months analysts have been covering SpringWorks Therapeutics stock. The most successful analyst is Robert Burns.